Summary
Cancer immunotherapy has recently become an important component of the combination treatment schedules for patients with multiple types of cancer. However, despite spectacular clinical responses in some patients, the immunosuppressive tumor microenvironment (TME) constitutes a...
More information & hyperlinks
Web resources: | https://immunologia.wum.edu.pl/en/node/192 |